These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24034666)

  • 1. Allopurinol on hypertension: insufficient evidence to recommend.
    Gois PH; Luchi WM; Seguro AC
    J Clin Hypertens (Greenwich); 2013 Sep; 15(9):700. PubMed ID: 24034666
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of allopurinol on blood pressure (author response to Allopurinol on hypertension: insufficient evidence to recommend).
    Agarwal V; Messerli F
    J Clin Hypertens (Greenwich); 2013 Sep; 15(9):701. PubMed ID: 24034667
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of allopurinol on blood pressure: a systematic review and meta-analysis.
    Agarwal V; Hans N; Messerli FH
    J Clin Hypertens (Greenwich); 2013 Jun; 15(6):435-42. PubMed ID: 23730993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout.
    Stocker SL; Graham GG; McLachlan AJ; Williams KM; Day RO
    J Rheumatol; 2011 May; 38(5):904-10. PubMed ID: 21285173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Not Available].
    Steurer J
    Praxis (Bern 1994); 2020; 109(13):1087-1088. PubMed ID: 33050820
    [No Abstract]   [Full Text] [Related]  

  • 6. [Time course of changes in the clinical manifestations of gout in men: data of a 7-year retrospective follow-up].
    Eliseev MS; Barskova VG; Denisov IS
    Ter Arkh; 2015; 87(5):10-15. PubMed ID: 26155614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiazide diuretics exacerbate fructose-induced metabolic syndrome.
    Reungjui S; Roncal CA; Mu W; Srinivas TR; Sirivongs D; Johnson RJ; Nakagawa T
    J Am Soc Nephrol; 2007 Oct; 18(10):2724-31. PubMed ID: 17855639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allopurinol and kidney function: An update.
    Stamp LK; Chapman PT; Palmer SC
    Joint Bone Spine; 2016 Jan; 83(1):19-24. PubMed ID: 26453097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association of Febuxostat Compared With Allopurinol on Blood Pressure and Major Adverse Cardiac Events Among Adult Patients With Hyperuricemia: A Meta-analysis.
    Barrientos-Regala M; Macabeo RA; Ramirez-Ragasa R; Pestaño NS; Punzalan FER; Tumanan-Mendoza B; Castillo RR
    J Cardiovasc Pharmacol; 2020 Oct; 76(4):461-471. PubMed ID: 32675751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperuricemia Inhibition Protects SD Rats Against Fructose-Induced Obesity Hypertension Via Modulation of Inflammation and Renin-Angiotensin System in Adipose Tissue.
    Zhang JX; Lin X; Xu J; Tang F
    Exp Clin Endocrinol Diabetes; 2021 Mar; 129(4):314-321. PubMed ID: 31683330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of allopurinol and benzbromarone on the concentration of uridine in plasma.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Yamakita J; Higashino K
    Metabolism; 1997 Dec; 46(12):1473-6. PubMed ID: 9439546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical inquiry. Are serum uric acid levels always elevated in acute gout?
    Leiszler M; Poddar S; Fletcher A
    J Fam Pract; 2011 Oct; 60(10):618-20. PubMed ID: 21977490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term allopurinol use decreases the risk of prostate cancer in patients with gout: a population-based study.
    Shih HJ; Kao MC; Tsai PS; Fan YC; Huang CJ
    Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):328-333. PubMed ID: 28398294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualising the dose of allopurinol in patients with gout.
    Kannangara DRW; Graham GG; Wright DFB; Stocker SL; Portek I; Pile KD; Barclay ML; Williams KM; Stamp LK; Day RO
    Br J Clin Pharmacol; 2017 Sep; 83(9):2015-2026. PubMed ID: 28417592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond urate lowering: Analgesic and anti-inflammatory properties of allopurinol.
    Schlesinger N; Brunetti L
    Semin Arthritis Rheum; 2020 Jun; 50(3):444-450. PubMed ID: 31839209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the treatment with allopurinol on the endothelial function in patients with hyperuricemia.
    Meléndez-Ramírez G; Pérez-Méndez O; López-Osorio C; Kuri-Alfaro J; Espinola-Zavaleta N
    Endocr Res; 2012; 37(1):1-6. PubMed ID: 21977925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol.
    Stamp LK; Taylor WJ; Jones PB; Dockerty JL; Drake J; Frampton C; Dalbeth N
    Arthritis Rheum; 2012 Aug; 64(8):2529-36. PubMed ID: 22488501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pallidifloside D from Smilax riparia enhanced allopurinol effects in hyperuricemia mice.
    Hou PY; Mi C; He Y; Zhang J; Wang SQ; Yu F; Anderson S; Zhang YW; Wu XH
    Fitoterapia; 2015 Sep; 105():43-8. PubMed ID: 26051087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Serum Urate Lowering With Allopurinol on Blood Pressure in Young Adults: A Randomized, Controlled, Crossover Trial.
    Gaffo AL; Calhoun DA; Rahn EJ; Oparil S; Li P; Dudenbostel T; Feig DI; Redden DT; Muntner P; Foster PJ; Biggers-Clark SR; Mudano A; Sattui SE; Saddekni MB; Bridges SL; Saag KG
    Arthritis Rheumatol; 2021 Aug; 73(8):1514-1522. PubMed ID: 33779064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitors of xanthine oxidoreductase].
    Okamoto K
    Nihon Rinsho; 2008 Apr; 66(4):748-53. PubMed ID: 18409526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.